A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis

Journal of Neuroscience

Volumn 25, Issue 10, 2005, Pages 2530-2536

  Benito, Cristina ^a   Kim, Wong Ki ^b   Chavarría, Iván ^a,c   Hillard, Ceceila J ^d   Mackie, Ken ^e   Tolón, Rosa M ^a   Williams, Ken ^b   Romero, Julián ^a,c  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Endocannabinoids; Gliosis; Immunohistochemistry; Macaques; Neuroinflammation; Viral encephalitis

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CD8 ANTIGEN; ENDOCANNABINOID;

ALZHEIMER DISEASE; ANTIVIRAL ACTIVITY; ARTICLE; ASTROCYTE; BRAIN; CELL INFILTRATION; ENCEPHALITIS; IMMUNOFLUORESCENCE; MACROPHAGE; MICROGLIA; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; UPREGULATION; VIRUS INFECTION; WESTERN BLOTTING;

AMIDOHYDROLASES; ANIMALS; BRAIN; ENCEPHALITIS, VIRAL; ENDOCANNABINOIDS; MACACA MULATTA; NEUROGLIA; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; UP-REGULATION;

EID: 14944367009     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3923-04.2005     Document Type: Article

References (43)

1. 2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 23:11136-11141.
2. 2 receptor-dependent mechanism. Mol Pharmacol 65:999-1007.
3. Croxford JL, Miller SD (2003) Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212. J Clin Invest 111:1231-1240.
4. 2 receptor in cell differentiation. J Biol Chem 275:15621-15628.
5. Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393:231-235.
6. Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017-1066.
7. Glass M, Dragunow M, Faull RL (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative auto radiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299-318.
8. Grundy RI, Rabuffetti M, Beltramo M (2001) Cannabinoids and neuroprotection. Mol Neurobiol 24:29-51.
9. Guzman M, Sanchez C, Galve-Roperh I (2002) Cannabinoids and cell fate. Pharmacol Ther 95:175-184.
10. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
11. Jorda MA, Rayman N, Valk P, De Wee E, Delwel R (2003) Identification, characterization, and function of a novel oncogene: the peripheral cannabinoid receptor Cb2. Ann NY Acad Sci 996:10-16.
12. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994.
13. Kim WK, Corey S, Chesney G, Knight H, Klumpp S, Wüthrich C, Letvin NL, Koralnik IJ, Lackner AA, Williams K (2004) Identification of T lymphocytes in simian immunodeficiency virus encephalitis: distribution of CD8+ T cells in association with central nervous system vessels and virus. J Neurovirol 10:315-325.
14. 2 receptor-dependent mechanism. J Biol Chem 278:24469-24475.
15. 2 receptor. Br J Pharmacol 139:775-786.
16. Kolson DL, Gonzalez-Scarano F (2000) HIV and HIV dementia. J Clin Invest 106:11-13.
17. Kolson DL, Lavi E, Gonzalez-Scarano F (1998) The effects of human immunodeficiency virus in the central nervous system. Adv Virus Res 50:1-47.
18. Lackner AA (1994) Pathology of simian immunodeficiency virus induced disease. Curr Top Microbiol Immunol 188:35-64.
19. Lynn AB, Herkenham M (1994) Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 268:1612-1623.
20. Maccarrone M, Piccirilli S, Battista N, Del Duca C, Nappi G, Corasaniti MT, Finazzi-Agro A, Bagetta G (2004) Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. J Neurochem 89:1293-1300.
21. Mechoulam R, Panikashvili D, Shohami E (2002) Cannabinoids and brain injury: therapeutic implications. Trends Mol Med 8:58-61.
22. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C (2002) The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 202:13-23.
23. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
24. Nath BM, Schumann KE, Boyer JD (2000) The chimpanzee and other nonhuman-primate models in HIV-1 vaccine research. Trends Microbiol 8:426-431.
25. Nunez E, Benito C, Pazos MR, Barbachano A, Fajardo O, Gonzalez S, Tolon RM, Romero J (2004) Cannabinoid CB(2) receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 53:208-213.
26. Pazos MR, Nunez E, Benito C, Tolon RM, Romero J (2004) Role of the endocannabinoid system in Alzheimer's disease: new perspectives. Life Sci 75:1907-1915.
27. Pertwee RG (2000) Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opin Invest Drugs 9:1553-1571.
28. Petry H, Luke W (1997) Infection of macaque monkeys with simian immunodeficiency virus: an animal model for neuro-AIDS. Intervirology 40:112-121.
29. Porter AC, Felder CC (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90:45-60.
30. Romero J, Hillard CJ, Calero M, Rabano A (2002) Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Brain Res Mol Brain Res 100:85-93.
31. Sanchez C, De Ceballos ML, Del Pulgar TG, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW, Cajal S, Guzman M (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61:5784-5789.
32. Schabitz WR, Giuffrida A, Berger C, Aschoff A, Schwaninger M, Schwab S, Piomelli D (2002) Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke 33:2112-2114.
33. Shi SR, Cote RJ, Taylor CR (2001) Antigen retrieval techniques: current perspectives. J Histochem Cytochem 49:931-937.
34. 1 receptors in the rat central nervous system. Neuroscience 83:393-411.
35. Tsou K, Nogueron MI, Muthian S, Sanudo-Pena MC, Hillard CJ, Deutsch DG, Walker JM (1998b) Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett 254:137-140.
36. Van der Stelt M, Veldhuis WB, Maccarrone M, Bar PR, Nicolay K, Veldink GA, Di Marzo V, Vliegenthart JF (2002) Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol Neurobiol 26:317-346.
37. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23:1398-1405.
38. Weber A, Ni J, Ling KH, Acheampong A, Tang-Liu DD, Burk R, Cravatt BF, Woodward D (2004) Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. J Lipid Res 45:757-763.
39. Whetter LE, Ojukwu IC, Novembre FJ, Dewhurst S (1999) Pathogenesis of simian immunodeficiency virus infection. J Gen Virol 80:1557-1568.
40. Williams K, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, Lackner AA (2001a) Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193:905-915.
41. Williams K, Alvarez X, Lackner AA (2001b) Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36:156-164.
42. Williams KC, Hickey WF (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25:537-562.
43. Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease - a double-edged sword. Neuron 35:419-432.